aTyr Pharma | LIFE - Assets


aTyr Pharma reported $106.65M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Alterity Therapeutics Limited AUD 27.32M 6.07M Jun/2023
Ardelyx USD 486.17M 19.4M Sep/2025
aTyr Pharma USD 106.65M 5.12M Sep/2025
Biogen USD 29.44B 232M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Cipla INR 401.64B 27.77B Sep/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 97.84M 8.68M Sep/2025
CSL USD 37.9B 1.5B Dec/2025
Curis USD 29.23M 10.09M Jun/2025
Galapagos EUR 3.41B 105.39M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Grifols EUR 23.29B 3.35M Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
United Therapeutics USD 7.88B 528.9M Dec/2025
Xoma USD 263.15M 39.7M Sep/2025